GLP-1 Receptor Agonists, Allostatic Load, and Reframing the Glaucoma Paradigm

Affiliations

¹ Department of Ophthalmology, Marengo Asia Hospitals, Gurugram, Haryana, India; Mayo Clinic, Jacksonville, Florida, USA.
² Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, USA.

Editorial

Shibal Bhartiya et al. J Curr Glaucoma Pract. 2025 Jan-Mar.

. 2025 Jan-Mar;19(1):1-2.

doi: 10.5005/jp-journals-10078-1471. Epub 2025 Mar 24.

¹ Department of Ophthalmology, Marengo Asia Hospitals, Gurugram, Haryana, India; Mayo Clinic, Jacksonville, Florida, USA.
² Department of Ophthalmology, Mayo Clinic, Jacksonville, Florida, USA.

No abstract available

Conflict of interest statement

Source of support: Nil Conflict of interest: NoneConflict of interest: None

1. Tham YC, Cheng CY. Associations between chronic systemic diseases and primary open angle glaucoma: an epidemiological perspective. Clin Exp Ophthalmol. 2017;45(1):24–32. doi: 10.1111/ceo.12763. - DOI - PubMed
1. Dada T, Mahalingam K, Gupta V. Allostatic load and glaucoma: are we missing the big picture? J Curr Glaucoma Pract. 2020;14(2):47–49. doi: 10.5005/jp-journals-10078-. - DOI - PMC - PubMed
1. Dada T, Verma S, Gagrani M, et al. Ocular and systemic factors associated with glaucoma. J Curr Glaucoma Pract. 2022;16(3):179–191. doi: 10.5005/jp-journals-10078-. - DOI - PMC - PubMed
1. Amaral DC, Guedes J, Cruz MRB, et al. GLP-1 receptor agonists use and incidence of glaucoma: a systematic review and meta-analysis. Am J Ophthalmol. 2025;271:488–497. doi: 10.1016/j.ajo.2024.12.024. - DOI - PubMed
1. Zhang Y, Huang S, Xie B, et al. Aging, cellular senescence, and glaucoma. Aging Dis. 2024;15(2):546–564. doi: 10.14336/AD.2023.0630-1. - DOI - PMC - PubMed